AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30499237 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin plus Saxagliptin (DAPA + SAXA)
Number of subjects: 461
Study 30499237 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin (SITA)
Number of subjects: 461
Study 29071409 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior-anterior stabilization
Number of subjects: 21
Study 29071409 — intervention group
Group type: COMPARATOR
Intervention: Posterior-only stabilization
Number of subjects: 21
Study 27809831 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored brief intervention (BI) incorporating motivational interviewing (MI) and personalized feedback.
Number of subjects: 0
Study 27809831 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored BI with modifications to 'Substance Use Risk' cards and 'Pros and Cons of Substance Use/Reasons to Quit or Cut Down'.
Number of subjects: 0
Study 25052972 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg submucosal dexamethasone injection
Number of subjects: 100
Study 25052972 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 100
Study 22381303 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG hydrogel (n = 120)
Number of subjects: 237
Study 22381303 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 117)
Number of subjects: 237
Study 22381303 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG hydrogel
Number of subjects: 237
Study 22381303 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 237
Study 20222106 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg subcutaneous 6 monthly)
Number of subjects: 247
Study 20222106 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg oral weekly)
Number of subjects: 247
Study 20222106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 20222106 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 247
Study 16959304 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparine 2850 units aXa/0.3 ml every 24 h during and 6 weeks after treatment
Number of subjects: 0
Study 16959304 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nadroparine)
Number of subjects: 0
Study 16959304 — intervention group
Group type: COMPARATOR
Intervention: Study group without nadroparine
Number of subjects: 0
Study 16335023 — intervention group
Group type: COMPARATOR
Intervention: Increasing the intake of cereals (especially breakfast cereals)
Number of subjects: 67
Study 16335023 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the intake of greens and vegetables
Number of subjects: 67
Study 12010240 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin treatment
Number of subjects: 120
Study 11472702 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin Infusion Prior to Stenting
Number of subjects: 179
Study 9745993 — intervention group
Group type: EXPERIMENTAL
Intervention: Step test protocol with cycle ergometer (3 steps, 25 Watt each for 6 min)
Number of subjects: 89
Study 9745993 — intervention group
Group type: EXPERIMENTAL
Intervention: Step test protocol with cycle ergometer
Number of subjects: 89
Study 8200332 — intervention group
Group type: EXPERIMENTAL
Intervention: Aludrox plus orange juice
Number of subjects: 15
Study 8200332 — intervention group
Group type: COMPARATOR
Intervention: Aludrox alone
Number of subjects: 15
Study 8200332 — intervention group
Group type: EXPERIMENTAL
Intervention: Aludrox plus milk
Number of subjects: 15
Study 2494620 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 199
Study 2494620 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic (Control)
Number of subjects: 199
Study 4554660 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam
Number of subjects: 22
Study 4554660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 464448 — intervention group
Group type: COMPARATOR
Intervention: UVB phototherapy
Number of subjects: 38
Study 31466932 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-headed toothbrush
Number of subjects: 60
Study 31466932 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual toothbrush
Number of subjects: 60
Study 31466932 — intervention group
Group type: COMPARATOR
Intervention: Comparison between triple-headed toothbrush and conventional manual toothbrush
Number of subjects: 60
Study 29850827 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia online educational intervention
Number of subjects: 111
Study 29850827 — intervention group
Group type: COMPARATOR
Intervention: Text-only online educational intervention
Number of subjects: 111
Study 26748347 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acid (PUFA) treatment (docosahexaenoic acid (DHA) and eicosapentaenoic acid) (Omacor/Lovaza, 4 g/day)
Number of subjects: 92
Study 26748347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 24760977 — intervention group
Group type: EXPERIMENTAL
Intervention: Fed-Ghrelin
Number of subjects: 21
Study 24760977 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted-Saline
Number of subjects: 21
Study 24760977 — intervention group
Group type: COMPARATOR
Intervention: Fed-Saline
Number of subjects: 21
Study 22685950 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher parental dental functional health literacy (FHL)
Number of subjects: 101
Study 22685950 — intervention group
Group type: EXPERIMENTAL
Intervention: Errors in completing the questionnaire
Number of subjects: 101
Study 20811761 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual component fibrin mesh (DCFM) (Tachosil, Nycomed, Marlow, UK)
Number of subjects: 0
Study 20811761 — intervention group
Group type: COMPARATOR
Intervention: Polypropylene mesh (PPM) (Prolene, Ethicon, Bracknell, UK)
Number of subjects: 0
Study 17671229 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtype B, E, and D immunoglobulin G capture immunoassay
Number of subjects: 0
Study 17671229 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment and further validation of the assay
Number of subjects: 0
Study 16223393 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 10 mg with fentanyl 15 microg
Number of subjects: 34
Study 16223393 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 10 mg with fentanyl 15 microg
Number of subjects: 34
Study 11962062 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antioxidants (vitamins E, C, beta-carotene) and minerals (zinc with copper)
Number of subjects: 0
Study 11962062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10234344 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective induction of labour at 41 weeks' gestation
Number of subjects: 0
Study 10234344 — intervention group
Group type: COMPARATOR
Intervention: Expectant management with selective labour induction
Number of subjects: 0
Study 10234344 — intervention group
Group type: EXPERIMENTAL
Intervention: Labour induction at 41 or more weeks' gestation
Number of subjects: 0
Study 7612076 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic strategy (perimetric measurement procedure with variable luminance-step sizes)
Number of subjects: 40
Study 7612076 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic strategy
Number of subjects: 40
Study 7612076 — intervention group
Group type: COMPARATOR
Intervention: Traditional strategy (4- to 2-dB strategy with fixed step sizes)
Number of subjects: 40
Study 1913041 — intervention group
Group type: EXPERIMENTAL
Intervention: Air aspiration after double-contrast knee arthrography
Number of subjects: 0
Study 1913041 — intervention group
Group type: COMPARATOR
Intervention: No air aspiration after double-contrast knee arthrography
Number of subjects: 0
Study 7016567 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole alone
Number of subjects: 9
Study 7016567 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole in combination with fenoterol
Number of subjects: 9
Study 7016567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30461207 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine (200 mg/m2 IV)
Number of subjects: 44
Study 30461207 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline IV)
Number of subjects: 44
Study 30461207 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine
Number of subjects: 44
Study 30461207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 28867766 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein meals (30%)
Number of subjects: 21
Study 28867766 — intervention group
Group type: COMPARATOR
Intervention: Normal protein meals (15%)
Number of subjects: 21
Study 26908625 — intervention group
Group type: EXPERIMENTAL
Intervention: SLC39A8 SNP (rs13107325)
Number of subjects: 18624
Study 26908625 — intervention group
Group type: EXPERIMENTAL
Intervention: NPPB variant
Number of subjects: 18624
Study 26908625 — intervention group
Group type: EXPERIMENTAL
Intervention: POC1B/GALNT4 SNP (rs11105306)
Number of subjects: 18624
Study 24400077 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion during normoglycemia (PG: 4.5 mM)
Number of subjects: 18
Study 24400077 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion during normoglycemia (PG: 4.5 mM)
Number of subjects: 18
Study 24400077 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion during hypoglycemia (PG: 3.0 mM)
Number of subjects: 18
Study 24400077 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion during hypoglycemia (PG: 3.0 mM)
Number of subjects: 18
Study 24400077 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 18
Study 22914601 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 238
Study 22914601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study 19168537 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided corticosteroid and lidocaine injection in the subacromial bursa
Number of subjects: 106
Study 19168537 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid and lidocaine injection in the gluteal region
Number of subjects: 106
Study 19168537 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided corticosteroid injection
Number of subjects: 106
Study 17148569 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone (8 mg/d)
Number of subjects: 20
Study 17148569 — intervention group
Group type: COMPARATOR
Intervention: metformin (2 g/d)
Number of subjects: 20
Study 16311459 — intervention group
Group type: EXPERIMENTAL
Intervention: Finometer
Number of subjects: 19
Study 16311459 — intervention group
Group type: COMPARATOR
Intervention: Finapres
Number of subjects: 19
Study 12239758 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalic vein cut-down (CCD)
Number of subjects: 50
Study 12239758 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous subclavian vein puncture (PSP)
Number of subjects: 50
Study 10191748 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin prophylaxis in patients with large blood loss (greater than 2 L)
Number of subjects: 13
Study 10191748 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin prophylaxis in patients with small blood loss (less than 2 L)
Number of subjects: 13
Study 10191748 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative 1.5 gram-dose of vancomycin for patients weighing more than 90 kg
Number of subjects: 13
Study 7577153 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation
Number of subjects: 20
Study 7577153 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K+D supplementation
Number of subjects: 20
Study 7577153 — intervention group
Group type: COMPARATOR
Intervention: Control (matched controls)
Number of subjects: 20
Study 2186854 — intervention group
Group type: EXPERIMENTAL
Intervention: Bestatin (30 mg daily after evacuation)
Number of subjects: 44
Study 2186854 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 44
Study 345341 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg glucagon
Number of subjects: 15
Study 345341 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg glucagon
Number of subjects: 15
Study 345341 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg glucagon
Number of subjects: 15
Study 345341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 29788532 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural magnesium sulphate (50 mg)
Number of subjects: 80
Study 29788532 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 80
Study 26718373 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound topical anesthetic (CTA)
Number of subjects: 24
Study 26718373 — intervention group
Group type: COMPARATOR
Intervention: Needle injection of local anesthetic
Number of subjects: 24
Study 25342618 — intervention group
Group type: EXPERIMENTAL
Intervention: x-linked retinitis pigmentosa (xlRP)
Number of subjects: 59
Study 25342618 — intervention group
Group type: COMPARATOR
Intervention: autosomal dominant retinitis pigmentosa (adRP)
Number of subjects: 59
Study 22678100 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal venous arterialization (DVA)
Number of subjects: 60
Study 22678100 — intervention group
Group type: COMPARATOR
Intervention: Antiaggregation therapy
Number of subjects: 60
Study 20966605 — intervention group
Group type: EXPERIMENTAL
Intervention: AAD plus enalapril
Number of subjects: 344
Study 20966605 — intervention group
Group type: COMPARATOR
Intervention: AAD alone
Number of subjects: 344
Study 18387222 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine (LCTZ), 5 mg
Number of subjects: 418
Study 18387222 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (MLKT), 10 mg
Number of subjects: 418
Study 18387222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study 16146574 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen challenge
Number of subjects: 69
Study 16146574 — intervention group
Group type: EXPERIMENTAL
Intervention: Pollen season exposure
Number of subjects: 69
Study 16146574 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 69
Study 11841418 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro purged PBSCs
Number of subjects: 60
Study 11841418 — intervention group
Group type: COMPARATOR
Intervention: Unmanipulated PBSCs
Number of subjects: 60
Study 11841418 — intervention group
Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 60
Study 10077045 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (1 g i.v. per day for 10 days)
Number of subjects: 34
Study 10077045 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (2 g i.v. per day for 10 days)
Number of subjects: 34
Study 10077045 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (1 g oral per day for 1.5 to 8 months)
Number of subjects: 34
Study 10077045 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (discontinuation after 1.5 to 8 months)
Number of subjects: 34
Study 10077045 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (no erythromycin)
Number of subjects: 34
Study 10077045 — intervention group
Group type: COMPARATOR
Intervention: WS patients with >3 years follow-up (no erythromycin)
Number of subjects: 34
Study 7561633 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (100 micrograms in 1 ml saline) injected as an i.v. bolus
Number of subjects: 13
Study 7561633 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexarelin (100 micrograms in 1 ml saline) injected as an i.v. bolus
Number of subjects: 13
Study 7561633 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexarelin (100 micrograms in 1 ml saline) plus GHRH (100 micrograms in 1 ml saline) injected as an i.v. bolus
Number of subjects: 13
Study 2185569 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol acetate (600 mg)
Number of subjects: 105
Study 2185569 — intervention group
Group type: COMPARATOR
Intervention: Placebo (600 mg)
Number of subjects: 105
Study 36111 — intervention group
Group type: EXPERIMENTAL
Intervention: fominoben
Number of subjects: 36
Study 36111 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study 36111 — intervention group
Group type: EXPERIMENTAL
Intervention: pethidine/promethazine
Number of subjects: 36
Study 31455459 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical significance criterion (CSC) endorsement
Number of subjects: 411
Study 31455459 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold depression symptoms
Number of subjects: 411
Study 31455459 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 411
Study 31028846 — intervention group
Group type: EXPERIMENTAL
Intervention: tRNS (transcranial random noise stimulation) over the left M1 for 10 min
Number of subjects: 16
Study 31028846 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 16
Study 28177133 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + dietary supplementation of low-dose omega-3 PUFAs (6.25 mg eicosapentaenoic acid and 19.19 mg docosahexaenoic acid)
Number of subjects: 30
Study 28177133 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + dietary supplementation of low-dose omega-3 PUFAs
Number of subjects: 30
Study 28177133 — intervention group
Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 30
Study 25148566 — intervention group
Group type: EXPERIMENTAL
Intervention: Take Charge of Your Life drug prevention program
Number of subjects: 0
Study 23887001 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional problem solving with feedback (unworked example)
Number of subjects: 120
Study 23887001 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert demonstration followed by problem solving with feedback (worked example)
Number of subjects: 120
Study 23887001 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 120
Study 23887001 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty physicians
Number of subjects: 120
Study 23887001 — intervention group
Group type: EXPERIMENTAL
Intervention: Resident physicians
Number of subjects: 120
Study 21772204 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular cartilage graft
Number of subjects: 20
Study 21772204 — intervention group
Group type: COMPARATOR
Intervention: Absorbable polyacid copolymer
Number of subjects: 20
Study 19197383 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 microg dose of MF59-adjuvanted H5N1 vaccine
Number of subjects: 486
Study 19197383 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 microg dose of MF59-adjuvanted H5N1 vaccine
Number of subjects: 486
Study 19197383 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations of MF59-adjuvanted H5N1 vaccine
Number of subjects: 486
Study 19197383 — intervention group
Group type: EXPERIMENTAL
Intervention: H5N1/turkey/Turkey/05 strain
Number of subjects: 486
Study 16861375 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (20 mg/day)
Number of subjects: 403
Study 16861375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study 16861375 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 403
Study 12751274 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg M100240 via short intravenous infusion
Number of subjects: 13
Study 12751274 — intervention group
Group type: COMPARATOR
Intervention: Oral immediate-release tablet administration
Number of subjects: 13
Study 12751274 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Enterion capsule delivery to the proximal small bowel
Number of subjects: 13
Study 12751274 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immediate-release formulation of M100240
Number of subjects: 13
Study 11083625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (400 mg t.i.d. for at least 72 h followed by 750 mg b.i.d. orally)
Number of subjects: 246
Study 11083625 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (2 g t.i.d. intravenously) plus Amikacin (500 mg b.i.d. intravenously)
Number of subjects: 246
Study 11083625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 246
Study 11083625 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus Amikacin
Number of subjects: 246
Study 9070558 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine
Number of subjects: 187
Study 9070558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 7845951 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions from four multicenter randomized clinical trials for diabetic retinopathy
Number of subjects: 0
Study 7845951 — intervention group
Group type: COMPARATOR
Intervention: No specific intervention mentioned
Number of subjects: 0
Study 2854609 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual prazepam 20 mg
Number of subjects: 5
Study 2854609 — intervention group
Group type: COMPARATOR
Intervention: Oral prazepam 20 mg
Number of subjects: 5
Study 2854609 — intervention group
Group type: EXPERIMENTAL
Intervention: N-desmethyl-diazepam (metabolite)
Number of subjects: 5
Study 2854609 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of area under the curve, maximum concentrations, and times to detect significant levels
Number of subjects: 5
Study 29577974 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitions to failure group (RFG, n=17)
Number of subjects: 52
Study 29577974 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitions not to failure group (NFG, n=20)
Number of subjects: 52
Study 29577974 — intervention group
Group type: EXPERIMENTAL
Intervention: Equalized volume group (ENFG, n=15)
Number of subjects: 52
Study 25671801 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 63
Study 25671801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 24365106 — intervention group
Group type: EXPERIMENTAL
Intervention: Long term practitioners (LTP)
Number of subjects: 0
Study 24365106 — intervention group
Group type: EXPERIMENTAL
Intervention: Short term meditators (STM)
Number of subjects: 0
Study 24365106 — intervention group
Group type: COMPARATOR
Intervention: Controls (non-meditators)
Number of subjects: 0
Study 24365106 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditators (LTP and STM combined)
Number of subjects: 0